Found 7 matching trials
Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule PHASE3 Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (...
Show More Location
GSK Investigational Site
Learn More & Join Trial
PCV10 Reactogenicity and Immunogenicity Study - Malindi PHASE4 The World Health Organization has recommended that developing countries sho...
Show More Location
Malindi District Hospital
Learn More & Join Trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe PHASE3 Primary objective:
This study aimed to demonstrate the non-inferiority of ...
Show More Location
Investigational Site Number : 2031006
Learn More & Join Trial
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants PHASE3 This study aims to evaluate the safety, reactogenicity and immunogenicity o...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine PHASE3 The purpose of this phase IIIb study is to determine whether children who h...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. PHASE3 This study will evaluate the safety, reactogenicity and immunogenicity of a...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose PHASE3 This primary purpose of this study is the evaluation of the immunological p...
Show More Location
GSK Investigational Site
Learn More & Join Trial